Michael Krumpel Email

Michael Krumpel Work

• 2024 -now Group Director Quality (Chief Quality Officer) @ Wörwag Pharma GmbH & Co. KG
• 2024 -now Committee Member „Pharmacy“ @ Bundesverband der Pharmazeutischen Industrie
• 2024 -now Global Quality Head @ AAA-Pharma GmbH
• 2022 -2024 Vice President Corporate Quality @ Aenova Group
• 2021 -2022 Corporate Quality Strategy Director @ Sanofi
  View Department
• 2020 -2021 Director and Head of the Bio 2.0 Quality Unit @ Sanofi
• 2020 -2020 Director and Head of Q Projects and Digital Q - Diabetes and Biosynthesis Operations Site Frankfurt @ Sanofi
• 2019 -2020 Head of Clinical Trial Supply Quality Assurance @ Merck Group
• 2018 -2019 Head of Site Quality Assurance - Gernsheim Site @ Merck Group
• 2016 -2017 Associate Director and Head of Biopharma QA Life Cycle Process and Cleaning Validation and Control Strategy @ Boehringer Ingelheim
• 2014 -2016 Deputy Lab Head - Biopharma Clinical Supply Quality Control and Analytical Development @ Boehringer Ingelheim
• 2014 -2014 Research Associate and Scientific Project Coordinator @ Karolinska Institutet
• 2012 -2013 Research Assistant (Scholarship Swedish Cancer and Allergy Foundation) @ Karolinska Institutet
• 2010 -2010 Research Scholar at the Nobel-Institute for Biochemistry and Scheele-Laboratoriet @ Karolinska Institutet
• 2010 -2010 Research Scholar at Lab of Maik Huttemann, Professor of Molecular Medicine and Division Director @ Karmanos Cancer Institute
• 2009 -2009 Research Scholar at Lab of Prem Ponka, Professor for Physiology and Director at Lady Davis Institute @ McGill University
• 2009 -2009 Research Scholar at Lab of Roland Lill, Professor of Clinical Cell Biology and Pathology @ The Philipp University of Marburg
• 2007 -2008 Research Technician at Lab of Fabian Kiessling, Professor of Radiology @ DKFZ German Cancer Research Center
• 2004 -2007 Research Technician at Lab of Tobias Stoeger, Comprehensive Pneumology Center @ Helmholtz Munich